![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 08, 2022 1:58:50 PM
Could see a nice buy out offer at some stage
Recent PHVS News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/11/2024 10:52:06 AM
- Pharvaris Announces Annual Meeting of Shareholders • GlobeNewswire Inc. • 06/11/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 08:05:02 PM
- Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses • GlobeNewswire Inc. • 06/04/2024 10:50:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/24/2024 09:04:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 09:54:50 PM
- Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses • GlobeNewswire Inc. • 05/13/2024 10:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 08:11:03 PM
- Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/08/2024 08:10:00 PM
- Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/10/2024 08:10:00 PM
- Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer • GlobeNewswire Inc. • 04/10/2024 08:08:00 PM
- Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference • GlobeNewswire Inc. • 04/04/2024 10:50:00 AM
- Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses • GlobeNewswire Inc. • 03/18/2024 10:50:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 05:51:18 PM
- Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/06/2024 09:40:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2024 09:15:02 PM
- Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses • GlobeNewswire Inc. • 03/06/2024 11:50:00 AM
- Pharvaris to Participate in the Leerink Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/05/2024 11:50:00 AM
- Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting • GlobeNewswire Inc. • 02/22/2024 11:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/16/2024 11:51:04 AM
- Pharvaris Announces Extraordinary Meeting of Shareholders • GlobeNewswire Inc. • 02/16/2024 11:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/07/2024 09:01:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 09:46:17 PM
- Pharvaris to Present at the WSAAI Annual Meeting 2024 • GlobeNewswire Inc. • 01/26/2024 11:50:00 AM
- Pharvaris Says FDA Lifted Clinical Hold on Application for Deucrictibant • Dow Jones News • 01/22/2024 12:35:00 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM